Strategic Acquisition SaveWay recently became part of Myonex, signaling a consolidated approach to clinical trial services and potential cross-sell opportunities with sponsors and patients across the United States.

Sterile Compounding Niche As Delaware’s only sterile compounding pharmacy, there is a defensible niche for pharmaceutical and veterinary clients seeking compliant sterile products and bundled compounding services.

Growth Potential With reported revenue in the mid single to low double digits and a small-to-mid sized team, there is a clear opportunity to scale operations, expand product lines, and extend distribution through Myonex network.

Tech Enablement Adoption of cloud, analytics, and security tools (Google Cloud, Microsoft 365, Clarity, Mixpanel, KnowBe4) can enhance customer engagement, data-driven sales outreach, and regulatory/compliance assurance for prospective clients.

Market Positioning Target near peers in specialty and compounding segments with potential for preferred provider status in both human and veterinary medicine, leveraging clinical trial services expansion to open new sponsor and site-level opportunities.